HOXD13 and cancer: Several animal studies have demonstrated sPD-1 local gene therapy delivery further improving anti-cancer immunity induced by other anti-cancer therapeutics when given in combination or to overcome therapy/vaccine-induced immune resistance (104, 115–118).